Nephron Pharmaceuticals Investing $313 Million in SC Expansion Expected to Create 707 Jobs
10/28/2011
Nephron is a global leader in manufacturing generic respiratory medications available to retail pharmacies, hospitals, home care companies and other customers. Its Orlando, Florida-based headquarters is comprised of 250,000-sq.-ft. of manufacturing, distribution and packaging facilities. The company has distribution centers in Kentucky and Arizona.
"We are excited to expand our company by locating our new manufacturing facility in Lexington County" said CEO Lou Kennedy. "This is a big step for our firm and will help us meet increased demand, expand our market share and develop our pipeline of products. South Carolina has an excellent business environment and we look forward to our expansion into the Palmetto State."
The South Carolina Dept. of Commerce has committed a set-aside grant of $4.5 million for site preparation and infrastructure. Nephron also was approved for job development credits, available when hiring targets are met. In addition, it will receive training support from the state's ReadySC program.
Project Announcements
Australia-Based Aquatic Leisure Technologies Group Plans Opp, Alabama, Manufacturing Operations
12/11/2025
Teradyne Plans Wixom, Michigan, Robotics Operations
12/11/2025
Robinson Plans Altoona, Iowa, Manufacturing Operations
12/11/2025
BioTouch Expands Columbus, Georgia, Operations
12/11/2025
Natrion Plans Erie County, New York, Battery Components Operations
12/11/2025
Czech-Based GZ PrintPak Expands Mount Pleasant, Wisconsin, Manufacturing Operations
12/11/2025
Most Read
-
The Workforce Bottleneck in America’s Manufacturing Revival
Q4 2025
-
Rethinking Local Governments Through Consolidation and Choice
Q3 2025
-
Lead with Facts, Land the Deal
Q3 2025
-
How Canada Stays Competitive
Q3 2025
-
Investors Seek Shelter in Food-Focused Real Estate
Q3 2025
-
America’s Aerospace Reboot
Q3 2025
-
The Permit Puzzle and the Path to Groundbreaking
Q3 2025